📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Radient Pharma

1.1 - Company Overview

Radient Pharma Logo

Radient Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cancer diagnostic tests and proprietary cancer vaccine technology, offering Onko-Sure, an in vitro blood test to detect and monitor solid tumor cancers by measuring Fibrin and Fibrinogen Degradation Products, and Combination Immunogene Therapy (CIT), designed to enhance the immune system’s ability to destroy cancer cells by incorporating genes into tumor cells.

Products and services

  • Combination Immunogene Therapy (CIT): A proprietary cancer vaccine technology that enhances immune-mediated tumor destruction by incorporating genes into tumor cells to amplify antitumor responses
  • Onko-Sure: An in vitro diagnostic blood test that detects and monitors solid tumor cancers by quantifying Fibrin and Fibrinogen Degradation Products (FDPs) circulating in patient blood.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Radient Pharma

Applied Microarrays Logo

Applied Microarrays

HQ: United States Website
  • Description: Provider of design, optimization and manufacturing services for DNA and protein biosensors and other microarrays on glass, plastic and semiconductors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Applied Microarrays company profile →
Personal Genome Diagnostics Logo

Personal Genome Diagnostics

HQ: United States Website
  • Description: Provider of patient-specific cancer genome analysis tools and comprehensive genomic profiling kits, including PGDx elio tissue complete (FDA cleared, CE-IVD marked) for in-house tumor profiling of over 500 genes identifying somatic mutations (SNVs, indels, TMB, MSI, select amplifications/translocations); PGDx elio plasma complete liquid biopsy for research across over 500 genes (SNVs, indels, bTMB, MSI, LOH); and PGDx elio plasma focus targeting 33 cancer genes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Personal Genome Diagnostics company profile →
Veracyte Logo

Veracyte

HQ: United States Website
  • Description: Provider of molecular diagnostic tests to improve patient outcomes and lower healthcare costs, including genomic classifiers: Afirma for thyroid cancer (RNA sequencing), Decipher Prostate for aggressiveness/metastasis risk, Envisia for differentiating IPF, Prosigna for early breast cancer recurrence risk, and Decipher Bladder to inform treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Veracyte company profile →
4D Lifetec Logo

4D Lifetec

HQ: Switzerland Website
  • Description: Provider of molecular diagnostic screening and test systems, including DNA defect and repair-based screening programs, and non-invasive immuno-oncological blood tests for early cancer detection. Offers 4D Lifetest to detect stages I and II via DNA fragmentation using the DDS biomarker, and 4D Lifetest Lung Dx for early-stage lung cancer, reducing invasive procedures and guiding treatment paths.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 4D Lifetec company profile →
InKaryo Logo

InKaryo

HQ: United States Website
  • Description: Provider of cytogenetic analysis services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InKaryo company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Radient Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Radient Pharma

2.2 - Growth funds investing in similar companies to Radient Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Radient Pharma

4.2 - Public trading comparable groups for Radient Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Radient Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Radient Pharma

What does Radient Pharma do?

Radient Pharma is a provider of cancer diagnostic tests and proprietary cancer vaccine technology, offering Onko-Sure, an in vitro blood test to detect and monitor solid tumor cancers by measuring Fibrin and Fibrinogen Degradation Products, and Combination Immunogene Therapy (CIT), designed to enhance the immune system’s ability to destroy cancer cells by incorporating genes into tumor cells.

Who are Radient Pharma's competitors?

Radient Pharma's competitors and similar companies include Applied Microarrays, Personal Genome Diagnostics, Veracyte, 4D Lifetec, and InKaryo.

Where is Radient Pharma headquartered?

Radient Pharma is headquartered in United States.

How many employees does Radient Pharma have?

Radient Pharma has 1,000 employees 🔒.

When was Radient Pharma founded?

Radient Pharma was founded in 2010 🔒.

What sector and industry vertical is Radient Pharma in?

Radient Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Radient Pharma

Who are the top strategic acquirers in Radient Pharma's sector and industry

Top strategic M&A buyers and acquirers in Radient Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Radient Pharma?

Top strategic M&A buyers groups and sectors for Radient Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Radient Pharma's sector and industry vertical

Which are the top PE firms investing in Radient Pharma's sector and industry vertical?

Top PE firms investing in Radient Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Radient Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Radient Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Radient Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Radient Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Radient Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Radient Pharma?

The key public trading comparables and valuation benchmarks for Radient Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Radient Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Radient Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Radient Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Radient Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Radient Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Radient Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Radient Pharma